abnormality – Page 55 – Communicable Diseases Research

Chest CT for early detection and management of coronavirus disease (COVID-19): a report of 314 patients admitted to Emergency Department with suspected pneumonia

Chest Radiology

Published on 2020-07-292022-10-28
Journal: La Radiologia Medica [Category] COVID-19, MERS, SARS,

COVID-19: immunopathogenesis and Immunotherapeutics

Review Article

Published on 2020-07-252022-10-04
Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, SARS, 바이오마커, 임상,

[키워드] Abnormalities abnormality activate acute respiratory syndrome Anti-viral immunity antiviral immune responses appear caused characterized clinical implication Clinical management clinical manifestations coronavirus COVID-19 Critical disease pathogenesis dysfunction granulocyte Host immune response immune immune response Immunopathogenesis immunopathology Immunotherapy include infected patient Infection Infectious diseases Inflammatory response inhibiting lymphocyte lymphopenia management mechanism microorganisms monocyte multiple organ dysfunction novel coronavirus disease outbreak Patient patients with COVID-19 potential mechanisms pro-inflammatory cytokine release rapid increase SARS-CoV-2 Septic shock severe COVID-19 systemic inflammation the disease therapeutic strategy Treatment
[DOI] 10.1038/s41392-020-00243-2 PMC 바로가기 [Article Type] Review Article

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease

Research Article

Published on 2020-07-232022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

[키워드] Abnormalities abnormality appear Arrhythmias assessment baseline Blood caused changes in Clinical data Clinical outcome coronavirus 2019 disease coronavirus disease Course COVID-19 diarrhea died dose evaluate failure grade 3 HCQ HCQ therapy highlighting Hospitalization hospitalized patient hospitals Hydroxychloroquine hypoxia IMPROVE in vitro activity in-hospital mortality incident liver mechanical ventilation New York City occurred outcomes Patient proportion QT prolongation randomized trials receiving requiring supplemental oxygen Respiratory Coronavirus Result retrospective cohort study Safe Safety SARS-CoV-2 supplemental oxygen sustained therapy Tolerability tolerable Treatment ventricular vomiting with COVID-19 worldwide pandemic
[DOI] 10.1371/journal.pone.0236778 PMC 바로가기 [Article Type] Research Article

Computed Tomography (CT) Imaging Features of Patients with COVID-19: Systematic Review and Meta-Analysis

Review Article

Published on 2020-07-232022-10-29
Journal: Radiology Research and Practice [Category] COVID-19,

COVID 19 – Clinical Picture in the Elderly Population: A Qualitative Systematic Review

Review

Published on 2020-07-232022-10-28
Journal: Aging and Disease [Category] COVID-19,

[키워드] abnormality Affect age Analysis approach article changes in clinical clinical feature Clinical features consolidations cough COVID 19 COVID-19 COVID-19 patient death duplicates Dyspnea elderly expected fatigue Fever Final fraction Ground glass opacity Hospitalized impairment indicated individual individuals Inflammation Injury Invasive mechanical ventilation Laboratory lymphopenia mechanical ventilation Mortality occurred Older older individuals organ damage outcome populations Predictive model Prominent Qualitative raise recorded renal reported required reveal review SARS-CoV-2 screened sputum production STROBE supplementary oxygen Symptom total patient was performed
[DOI] 10.14336/AD.2020.0620 PMC 바로가기 [Article Type] Review

The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System

Immunology

Published on 2020-07-222022-11-01
Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS,

[키워드] abnormality acute respiratory syndrome affecting bidirectional cause circulatory system coronavirus diabetic patient disease Diseases Effect explain Fatty liver gut microbiota hyperinsulinemia immune cell functions Immune cell infiltration immune system immunization immunological immunometabolism impairment increase inducer Infectious diseases Inflammation insulin resistance intestinal permeability mechanisms metabolic Metabolic abnormality metabolic factors metabolism obesity occur organ Organ failure oxidative stress pathogenic agent Patient Premature progression promote protocol regulate SARS-CoV-2 subsequent susceptibility susceptible System systemic low-level inflammation tissue turn Type type 2 diabete Type 2 diabetes mellitus
[DOI] 10.3389/fimmu.2020.01582 PMC 바로가기 [Article Type] Immunology

Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data

Medicine

Published on 2020-07-212022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] abnormality association available data cause Clinical outcome clinical study Clinicians COVID-19 COVID-19 outbreak COVID-19 patient demonstrated drug evaluate higher risk Hospitalization identify immune-mediated inflammation Infection Injury Laboratory tests liver Liver damage Liver disease liver enzymes Liver injury marker Mortality occur other organ outcome patients with COVID-19 progression provide public health recent recommendation relationship review Ritonavir SARS-CoV-2 Serum level severe cases Severe patient severe SARS-CoV-2 significantly higher total bilirubin Toxicity Treatment virus with COVID-19
[DOI] 10.3389/fmed.2020.00458 PMC 바로가기 [Article Type] Medicine

Utility of D-dimer as a Prognostic Factor in SARS CoV2 Infection: A Review

Article

Published on 2020-07-212022-10-27
Journal: American journal of medical case reports [Category] COVID-19,

[키워드] abnormality acute respiratory distress anticoagulation ARDS benefit Case report clinical decision Coagulopathy Cohort studies Corona virus coronavirus disease-2019 COVID-19 COVID-19 infection COVID-19 patient Critically ill D-dimer D-dimer level death disease severity Disseminated intravascular coagulation Efficacy elevated event Evidence evidenced Factor help immune dysregulation implicated increased mortality manifestation microvascular thrombosis and macrovascular thrombosis Mortality non-survivor pandemic Patient pediatric Pneumonia Population predict progression public health emergency randomized control trial regimen review risk risk stratification Severe COVID-19 pneumonia severity of COVID-19 shown suggested Survivors syndrome therapeutic anticoagulation thromboembolic Thromboembolic events utility venous thromboembolic virus WHO World Health Organization
PMC 바로가기 [Article Type] Article

Point-of-care Lung Ultrasound Is More Sensitive than Chest Radiograph for Evaluation of COVID-19

Endemic Infections

Published on 2020-07-192022-10-28
Journal: Western Journal of Emergency Medicine [Category] COVID-19, SARS,

Early Warning Indicators of Severe COVID-19: A Single-Center Study of Cases From Shanghai, China

Medicine

Published on 2020-07-172022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] abnormal coagulation abnormality addition Admission Adult adult COVID-19 patient age Analysis C-reactive protein CD4/CD8 center China clinical Comorbidities condition COVID-19 Critical D-dimer death develop diabete disease Disease progression early warning indicators epidemiological examined four group higher risk identify Indicator Laboratory lactate dehydrogenase Lymphocytes management Mild moderate moderate disease moderate patients Neutrophils novel coronavirus disease organ damage Patient patients predictor procalcitonin prognostic progressed progression Public remained risk factor serum severe COVID-19 severe disease severe patients Shanghai Shortness of breath survival curve treated
[DOI] 10.3389/fmed.2020.00432 PMC 바로가기 [Article Type] Medicine